Takeda Pharma says Japan approves 2 flu vaccine drugs
TOKYO, March 31
TOKYO, March 31 (Reuters) - Takeda Pharmaceutical Co Ltd said on Monday it had received approval to manufacture and supply two vaccines for prevention of pandemic influenza from the Japanese health ministry.
The New Drug Application for the vaccines, H5N1 "Takeda" and "Takeda", was submitted in March 2013.
Takeda had entered a development, licensing and technology transfer agreement with Baxter International Inc in 2010 in which Baxter licensed exclusive rights to its cell culture-based pandemic flu vaccine technology for the Japanese market. (Reporting by Chang-Ran Kim; Editing by Dominic Lau)
- Tesla says in talks with BMW over car batteries, parts
- Hagel, under pressure, resigns as defense secretary |
- Missouri grand jury makes decision in fatal shooting of black teen |
- Iran nuclear talks extended seven months after failing to meet deadline |
- Actor Dwight Henry eyed in New Orleans killing after arrest for theft